Perakizumab

From WikiMD's WELLNESSPEDIA

Perakizumab















Identifiers
CAS Number 89957-37-9



ChemSpider none




Chemical data


Chemical formula C6454H9964N1718O2030S44
Molecular weight 145.4 kg/mol





Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis.[1] It binds to IL17A and acts as an immunomodulator.[2]

This drug was developed by Genentech/Roche.

References[edit]

  1. ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Perakizumab, American Medical Association.
  2. ↑ World Health Organization."International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107".WHO Drug Information.2012;26(2)Full text.


Monoclonal antibodies for the immune system
Immune system
Human
Mouse
Chimeric
Humanized
* Immunosuppressive: Apolizumab§

Immune activation: Dostarlimab

Other: Ibalizumab
Chimeric + humanized
Interleukin
Inflammatory lesions



Stub icon

This monoclonal antibody–related article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Perakizumab&oldid=6525708"